These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7533414

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL, Knowles RW, Colvin RB, Cavender DE, Kawai T, Bedle M, Stroka D, Preffer FI, Haug C, Cosimi AB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Nonresponsiveness induced in fetal pancreas allografts by pretreatment with donor spleen cells and anti-CD4 monoclonal antibodies prior to grafting.
    Thompson SC, Mandel TE.
    Transplant Proc; 1990 Apr; 22(2):882-3. PubMed ID: 2327031
    [No Abstract] [Full Text] [Related]

  • 49. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
    Orosz CG, Wakely E, Bergese SD, VanBuskirk AM, Ferguson RM, Mullet D, Apseloff G, Gerber N.
    Transplantation; 1996 Mar 15; 61(5):783-91. PubMed ID: 8607184
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies.
    Mottram PL, Wheelahan J, Mirisklavos A, Clunie GJ, McKenzie IF.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 1):582-5. PubMed ID: 3103281
    [No Abstract] [Full Text] [Related]

  • 52. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS.
    J Exp Med; 1994 Jan 01; 179(1):341-6. PubMed ID: 7903681
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Lacto-N-fucopentaose III, a pentasaccharide, prolongs heart transplant survival.
    Dutta P, Hullett DA, Roenneburg DA, Torrealba JR, Sollinger HW, Harn DA, Burlingham WJ.
    Transplantation; 2010 Nov 27; 90(10):1071-8. PubMed ID: 20885339
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Role of the endothelial adhesion molecule VCAM in murine cardiac allograft rejection.
    Orosz CG, van Buskirk A, Sedmak DD, Kincade P, Miyake K, Pelletier RP.
    Immunol Lett; 1992 Mar 27; 32(1):7-12. PubMed ID: 1379979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.